"Injecting a Dose of Hope and Urgency in the Fight…"

Connecting ALS - A podcast by ALS Association

Categories:

Society & Culture

Welcome to Connecting ALS. This week we continue the discussion around Amylyx Pharmaceutical’s phase 2 clinical trial results of AMX0035, which was shown to slow down progression of ALS in trial participants.